Aminoglycoside

DRUG5 trials

Conditions

Acute Kidney InjuryAminoglycoside ToxicityCystic FibrosisCystic Fibrosis Pulmonary ExacerbationInfectionLate-onset SepsisProsthetic Valve EndocarditisRenal Dysfunction

Phase 2

Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis

TerminatedNCT02424734

PfizerLate-onset Sepsis

Start: 2015-08-04End: 2017-12-26Updated: 2018-09-13

Phase 4

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

RecruitingNCT05548283

Chris GossCystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation

Start: 2023-04-23End: 2026-11-15Target: 730Updated: 2024-08-26

Unknown Phase

Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children

CompletedNCT00308906

Virginia Commonwealth UniversityInfection, Renal Dysfunction

Start: 2006-06-30End: 2010-12-31Updated: 2016-02-02

Prosthetic Valve Sweing Ring Injection by Antiboitics Can Affect the Rate of Postoperative Infective Endocarditis?

NCT05455788

Assiut UniversityProsthetic Valve Endocarditis

Start: 2021-12-01End: 2023-12-15Target: 300Updated: 2022-07-13

Risk Factors and Machine Learning Model for Aminoglycines Related Acute Kidney Injury

CompletedNCT05533593

Qianfoshan HospitalAcute Kidney Injury, Aminoglycoside Toxicity

Start: 2022-07-01End: 2023-10-31Updated: 2023-11-18

Related Papers

Machine learning modeling for the risk of acute kidney injury in inpatients receiving amikacin and etimicin

Frontiers in Pharmacology2025-05-228 citations

Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis